Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

SYN-115 enhances effects of levodopa in Parkinson's disease patients

Feb. 4, 2010

GI-4000 plus gemcitabine evaluated in ras mutation-bearing pancreas cancer

Feb. 3, 2010

MK-0646 added to gemcitabine and erlotinib active in advanced pancreatic cancer

Feb. 3, 2010

Perifosine plus capecitabine active in mCRC; phase III study planned

Feb. 3, 2010

PHY-906 beneficial when added to capecitabine in phase II pancreatic cancer trial

Feb. 3, 2010

Rilotumumab dose selected for randomized evaluation with panitumumab in mCRC

Feb. 2, 2010

Combination of pasireotide and everolimus feasible for neuroendocrine tumors

Feb. 2, 2010

Phase II data show everolimus monotherapy to be safe and active in metastatic gastric cancer

Feb. 2, 2010

First phase I trial of KRN-330 supports safety and tolerability in advanced CRC

Feb. 2, 2010

Promising data disclosed on TNFerade for esophageal cancer

Feb. 2, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...